Thus, it was not unexpected to find that CD4+ T cells in patients with SCCHN were characterised by the loss of CCR7 and L-selectin surface molecules, which are functionally associated with cell migration into tissues and serve as phenotypic markers for distinct stages of lymphocyte differentiation, respectively. The gene discussed is SELL; the disease is head and neck squamous cell carcinoma.